We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+16.68%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$88.8B
AUM Growth
+$10B
(+13%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
31.47%
Holding
3,325
New
753
Increased
947
Reduced
893
Closed
691
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRCL
Circle Internet Group
CRCL
|
+$1.39B |
| 2 |
NVIDIA
NVDA
|
+$910M |
| 3 |
Amazon
AMZN
|
+$440M |
| 4 |
T-Mobile US
TMUS
|
+$432M |
| 5 |
Eli Lilly
LLY
|
+$398M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.3B |
| 2 |
Tesla
TSLA
|
+$880M |
| 3 |
Danaher
DHR
|
+$535M |
| 4 |
Intuit
INTU
|
+$467M |
| 5 |
Visa
V
|
+$437M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.88% |
| 2 | Consumer Discretionary | 13.54% |
| 3 | Healthcare | 10.42% |
| 4 | Financials | 8.78% |
| 5 | Communication Services | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Relay Therapeutics
RLAY
$4.37B
| $179K | ﹤0.01% |
+51,698
| New | +$154K |
|
2452
Leslie's
LESL
$10.4M
| $177K | ﹤0.01% |
21,064
+18,534
| +733% | +$244K |
|
2453
Gencor Industries
GENC
$235M
| $176K | ﹤0.01% |
12,540
-13,764
| -52% | -$180K |
|
2454
LiveOne
LVO
$60.4M
| $174K | ﹤0.01% |
+23,144
| New | +$172K |
|
2455
Grupo Aval
AVAL
$6.27B
| $171K | ﹤0.01% |
60,733
+25,753
| +74% | +$70.6K |
|
2456
Evotec
EVO
$739M
| $169K | ﹤0.01% |
+40,310
| New | +$158K |
|
|
USAS
2457
Americas Gold and Silver
USAS
$1.73B
| $169K | ﹤0.01% |
83,440
-194,164
| -70% | -$314K |
|
2458
Sutro Biopharma
STRO
$423M
| $166K | ﹤0.01% |
+23,443
| New | +$192K |
|
|
CLPR
2459
Clipper Realty
CLPR
$47.2M
| $165K | ﹤0.01% |
44,987
+1,269
| +3% | +$4.85K |
|
2460
CALL
iShares US Transportation ETF
IYT
$2.27B
| $164K | ﹤0.01% |
+2,400
| New | +$153K |
|
2461
AbCellera Biologics
ABCL
$2.85B
| $163K | ﹤0.01% |
47,480
| – | – |
|
2462
Pyxis Oncology
PYXS
$243M
| $163K | ﹤0.01% |
+147,771
| New | +$166K |
|
2463
Digimarc Corp
DMRC
$168M
| $162K | ﹤0.01% |
12,276
-101,974
| -89% | -$1.31M |
|
|
QIPT
2464
DELISTED
Quipt Home Medical
QIPT
| $162K | ﹤0.01% |
+90,514
| New | +$179K |
|
2465
Wave Life Sciences
WVE
$1.2B
| $161K | ﹤0.01% |
+24,828
| New | +$164K |
|
2466
Mammoth Energy Services
TUSK
$162M
| $161K | ﹤0.01% |
+57,436
| New | +$147K |
|
2467
Lufax Holding
LU
$1.44B
| $160K | ﹤0.01% |
+57,404
| New | +$162K |
|
2468
Acumen Pharmaceuticals
ABOS
$176M
| $160K | ﹤0.01% |
+137,943
| New | +$148K |
|
2469
PUT
Alibaba
BABA
$317B
| $159K | ﹤0.01% |
1,400
-231,000
| -99% | -$27.3M |
|
2470
Invivyd
IVVD
$198M
| $158K | ﹤0.01% |
+222,633
| New | +$158K |
|
|
SVCO
2471
Silvaco Group
SVCO
$247M
| $157K | ﹤0.01% |
33,269
-20,769
| -38% | -$98.3K |
|
|
AIV
2472
Aimco
AIV
$377M
| $156K | ﹤0.01% |
+18,085
| New | +$146K |
|
2473
Neuronetics
STIM
$151M
| $151K | ﹤0.01% |
43,243
-11,275
| -21% | -$44.5K |
|
|
AIRJ
2474
Montana Technologies Corp
AIRJ
$429M
| $151K | ﹤0.01% |
32,555
-80,139
| -71% | -$368K |
|
2475
Rockwell Medical
RMTI
$27M
| $148K | ﹤0.01% |
17,378
-15,982
| -48% | -$163K |
|
Similar funds
Marshall Wace's Q2 2025 Portfolio in Review
As of Q2 2025, Marshall Wace held 3,325 positions worth $88.8B, up 13% from $78.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marshall Wace's Q2 2025 filing shows 753 new, 947 increased, 893 reduced and 691 closed positions. Its largest new stake was Circle Internet Group: 8,534,470 shares worth $1.55B. The largest sale was iShares Core S&P 500 ETF, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q2 2025 buy was Circle Internet Group: 8,534,470 shares worth $1.55B.
- Marshall Wace added most to NVIDIA in Q2 2025, an estimated $910M increase.
- Marshall Wace's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.3B.
- Marshall Wace fully exited Cboe Global Markets in Q2 2025, selling an estimated $191M.
- Marshall Wace's ten largest holdings make up 31% of its $88.8B portfolio in Q2 2025.
- Marshall Wace opened 753 new positions and closed 691 in Q2 2025.
- Marshall Wace's portfolio value rose 13% quarter-over-quarter to $88.8B.
Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.